Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sotera Health (SHC) EPS (Weighted Average and Diluted) (2020 - 2025)

Sotera Health has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at $0.12 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at $0.12 for Q4 2025, up 140.0% from a year ago — trailing twelve months through Dec 2025 was $0.27 (up 68.75% YoY), and the annual figure for FY2025 was $0.27, up 68.75%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.12 at Sotera Health, down from $0.17 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for SHC hit a ceiling of $0.17 in Q3 2025 and a floor of -$1.14 in Q4 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.07 (2023), compared with a mean of $0.01.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 3594.75% in 2021 and later crashed 1050.0% in 2022.
  • Sotera Health's EPS (Weighted Average and Diluted) stood at $0.12 in 2021, then tumbled by 1050.0% to -$1.14 in 2022, then soared by 112.28% to $0.14 in 2023, then tumbled by 64.29% to $0.05 in 2024, then soared by 140.0% to $0.12 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.12 (Q4 2025), $0.17 (Q3 2025), and $0.03 (Q2 2025) per Business Quant data.